Related Experiment Videos
Bioavailability of rectally administered valproic acid syrup
Neurology
|October 1, 1981
Summary
Rectal administration of valproic acid (VPA) syrup shows comparable bioavailability to oral doses in dogs and children. This suggests rectal VPA syrup is a viable alternative when oral intake is not possible.
Area of Science:
- Pharmacokinetics
- Drug bioavailability studies
Background:
- Valproic acid (VPA) is a widely used antiepileptic drug.
- Assessing alternative administration routes is crucial for patient adherence and therapeutic efficacy.
Observation:
- A study compared the bioavailability of valproic acid syrup via oral (PO) and rectal (PR) routes in dogs.
- Absorption following rectal administration of VPA syrup was evaluated in pediatric patients.
Findings:
- In dogs, no significant difference in the area under the serum concentration-time curve (AUC) was observed between PO and PR VPA administration.
- Rectal VPA absorption in children on maintenance therapy was comparable to oral administration.
- In one child, rectal VPA achieved peak serum levels of 42 mg/L within 2 hours post-administration.
Implications:
- Diluted valproic acid syrup demonstrates comparable bioavailability via rectal and oral routes.
- Rectal administration of VPA syrup presents a suitable alternative for patients unable to take medication orally.